Italy Avian Influenza Vaccine Market

ID: MRFR/Pharma/48050-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026
Italy Avian Influenza Vaccine Market Research Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Administration Route (Intramuscular, Subcutaneous, Waterborne), By Target Species (Broilers, Layers, Breeders, Backyard Poultry) andBy Distribution Channel (Veterinary Clinics, Online Pharmacies, Retail Stores) - Growth & Industry Forecast 2025 To 2035
Italy Avian Influenza Vaccine Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.78%
2024 Market Size$ 147.9 Million
2025 Market Size$ 152.01 Million
2035 Market Size$ 200 Million
Key Players
Boehringer Ingelheim
Merck Animal Health
Zoetis
Ceva Santé Animale
Heska Corporation
Vetoquinol
Trends
  • Regulatory Influence on Vaccine Development
  • Technological Advancements in Vaccination
  • Focus on Biosecurity and Animal Welfare
Opportunities
  • Rising Avian Influenza Incidence
  • Advancements in Vaccine Technology
  • Government Initiatives and Funding
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Type (USD Million)
      1. 4.1.1 Live Attenuated Vaccines
      2. 4.1.2 Inactivated Vaccines
      3. 4.1.3 Recombinant Vaccines
      4. 4.1.4 Subunit Vaccines
    2. 4.2 Construction, BY Administration Route (USD Million)
      1. 4.2.1 Intramuscular
      2. 4.2.2 Subcutaneous
      3. 4.2.3 Waterborne
    3. 4.3 Construction, BY Target Species (USD Million)
      1. 4.3.1 Broilers
      2. 4.3.2 Layers
      3. 4.3.3 Breeders
      4. 4.3.4 Backyard Poultry
    4. 4.4 Construction, BY Distribution Channel (USD Million)
      1. 4.4.1 Veterinary Clinics
      2. 4.4.2 Online Pharmacies
      3. 4.4.3 Retail Stores
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boehringer Ingelheim (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Merck Animal Health (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Zoetis (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Ceva Santé Animale (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Heska Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Vetoquinol (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Elanco Animal Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Virbac (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 ITALY MARKET ANALYSIS BY TYPE
    3. 6.3 ITALY MARKET ANALYSIS BY ADMINISTRATION ROUTE
    4. 6.4 ITALY MARKET ANALYSIS BY TARGET SPECIES
    5. 6.5 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY TARGET SPECIES, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY TARGET SPECIES, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Million)
      3. 7.2.3 BY TARGET SPECIES, 2025-2035 (USD Million)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Italy Avian Influenza Vaccine Market Segmentation

Italy Avian Influenza Vaccine Market By Type (USD Million, 2025-2035)

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

Italy Avian Influenza Vaccine Market By Administration Route (USD Million, 2025-2035)

  • Intramuscular
  • Subcutaneous
  • Waterborne

Italy Avian Influenza Vaccine Market By Target Species (USD Million, 2025-2035)

  • Broilers
  • Layers
  • Breeders
  • Backyard Poultry

Italy Avian Influenza Vaccine Market By Distribution Channel (USD Million, 2025-2035)

  • Veterinary Clinics
  • Online Pharmacies
  • Retail Stores

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.